1dxp: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
|PDB= 1dxp |SIZE=350|CAPTION= <scene name='initialview01'>1dxp</scene>, resolution 2.4Å | |PDB= 1dxp |SIZE=350|CAPTION= <scene name='initialview01'>1dxp</scene>, resolution 2.4Å | ||
|SITE= <scene name='pdbsite=ZN1:Zn+Binding+Site+Chain+A'>ZN1</scene> and <scene name='pdbsite=ZN2:Zn+Binding+Site+Chain+B'>ZN2</scene> | |SITE= <scene name='pdbsite=ZN1:Zn+Binding+Site+Chain+A'>ZN1</scene> and <scene name='pdbsite=ZN2:Zn+Binding+Site+Chain+B'>ZN2</scene> | ||
|LIGAND= <scene name='pdbligand= | |LIGAND= <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene> | ||
|ACTIVITY= | |ACTIVITY= | ||
|GENE= HCV ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id= Hepatitis C virus genotype 1a (isolate 1)]) | |GENE= HCV ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id= Hepatitis C virus genotype 1a (isolate 1)]) | ||
|DOMAIN= | |||
|RELATEDENTRY= | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1dxp FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1dxp OCA], [http://www.ebi.ac.uk/pdbsum/1dxp PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1dxp RCSB]</span> | |||
}} | }} | ||
| Line 16: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
1DXP is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/ | 1DXP is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus Hepatitis c virus] and [http://en.wikipedia.org/wiki/Hepatitis_c_virus_genotype_1a_(isolate_1) Hepatitis c virus genotype 1a (isolate 1)]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DXP OCA]. | ||
==Reference== | ==Reference== | ||
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes., Di Marco S, Rizzi M, Volpari C, Walsh MA, Narjes F, Colarusso S, De Francesco R, Matassa VG, Sollazzo M, J Biol Chem. 2000 Mar 10;275(10):7152-7. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10702283 10702283] | Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes., Di Marco S, Rizzi M, Volpari C, Walsh MA, Narjes F, Colarusso S, De Francesco R, Matassa VG, Sollazzo M, J Biol Chem. 2000 Mar 10;275(10):7152-7. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/10702283 10702283] | ||
[[Category: | [[Category: Hepatitis c virus]] | ||
[[Category: Hepatitis c virus genotype 1a (isolate 1)]] | [[Category: Hepatitis c virus genotype 1a (isolate 1)]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
| Line 32: | Line 35: | ||
[[Category: Volpari, C.]] | [[Category: Volpari, C.]] | ||
[[Category: Walsh, M.]] | [[Category: Walsh, M.]] | ||
[[Category: hepatitis c virus]] | [[Category: hepatitis c virus]] | ||
[[Category: ns3]] | [[Category: ns3]] | ||
| Line 40: | Line 41: | ||
[[Category: serine protease]] | [[Category: serine protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 19:50:53 2008'' | ||
Revision as of 19:50, 30 March 2008
| |||||||
| , resolution 2.4Å | |||||||
|---|---|---|---|---|---|---|---|
| Sites: | and | ||||||
| Ligands: | , | ||||||
| Gene: | HCV (Hepatitis C virus genotype 1a (isolate 1)) | ||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (APO STRUCTURE)
OverviewOverview
The hepatitis C virus NS3 protein contains a serine protease domain with a chymotrypsin-like fold, which is a target for development of therapeutics. We report the crystal structures of this domain complexed with NS4A cofactor and with two potent, reversible covalent inhibitors spanning the P1-P4 residues. Both inhibitors bind in an extended backbone conformation, forming an anti-parallel beta-sheet with one enzyme beta-strand. The P1 residue contributes most to the binding energy, whereas P2-P4 side chains are partially solvent exposed. The structures do not show notable rearrangements of the active site upon inhibitor binding. These results are significant for the development of antivirals.
About this StructureAbout this Structure
1DXP is a Protein complex structure of sequences from Hepatitis c virus and Hepatitis c virus genotype 1a (isolate 1). Full crystallographic information is available from OCA.
ReferenceReference
Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes., Di Marco S, Rizzi M, Volpari C, Walsh MA, Narjes F, Colarusso S, De Francesco R, Matassa VG, Sollazzo M, J Biol Chem. 2000 Mar 10;275(10):7152-7. PMID:10702283
Page seeded by OCA on Sun Mar 30 19:50:53 2008